UCB presents new data at 35th International Epilepsy Congress (IEC) highlighting important advancements across Fintepla®▼(fenfluramine) oral solution and broader epilepsies portfolio

UCB presents new data at 35th International Epilepsy Congress (IEC) highlighting important advancements across Fintepla®▼(fenfluramine) oral solution and broader epilepsies portfolio

Related Keywords

Lingfield ,Surrey ,United Kingdom ,Brussels ,Bruxelles Capitale ,Belgium ,London ,City Of ,Orrin Devinsky ,Encephalopathies Dees ,Helen Cross ,Mike Davis ,Institute Of Child Health ,European Society Of Cardiology ,Langone Health Comprehensive Epilepsy Center ,International Epilepsy Congress ,European Respiratory Society ,Seizure Termination Project ,Rapid Early Seizure Termination ,Global Epilepsy ,Rare Syndromes ,Epileptic Encephalopathies ,Professor Helen Cross ,Childhood Epilepsy ,Ormond Street Institute ,Child Health ,Young Epilepsy ,Sudden Unexpected Death ,Comprehensive Epilepsy Center ,Early Seizure ,Seizure Termination ,European Summary ,Product Characteristics ,Safety Information ,